Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02478931 · ClinicalTrials.gov registry record
Study of Personalized Cancer Therapy to Determine Response and Toxicity
A clinical trial of Cancer, sponsored by Shu Mei Kato.
- Recruiting
- Registry status
- 10,000
- Enrollment target
- 3
- Study locations
NCT02478931 is a study of Cancer that is actively recruiting participants, run by Shu Mei Kato. The registered enrollment target is 10,000 participants, above the 3,475-participant average among 615 other Cancer trials with a reported enrollment target (188% higher). The trial reports 3 study locations across 1 state.
The verdict
NCT02478931, a study of Cancer, is actively recruiting participants, sponsored by Shu Mei Kato.
- RECRUITING
- Registry status
- 10,000 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to learn more about personalized cancer therapy including response to treatment and side effects. Information about the tests and treatments a person received, or will receive, for their cancer will be collected from medical records to help the researchers determine whether or not patients respond better when their physicians choose to treat them according to the genetic makeup of their tumor. Optional research tests may be performed on tissue, body cavity fluid, blood or urine provided, discarded biological samples taken during routine care that would normally be disposed of and not saved, or on blood samples collected for this study. These research tests will be used to create a "profile" of the collected specimens which will describe unique characteristics about the genes involved in a person's cancer. The tests will also help researchers look for biomarkers that may help predict how people respond to treatment.
Conditions Studied
Study Locations (3)
California
- UCSD Moores Cancer Center - La Jolla
- Eisenhower Medical Center, Lucy Curci Cancer Center - Rancho Mirage
- Rady Children's Hospital, San Diego - San Diego
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10,000 participants |
| Start Date | 2013-09-05 |
| Est. Completion | 2026-09-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02478931
The ClinicalTrials.gov registry entry for NCT02478931 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 10,000 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,475-participant average among 615 other Cancer trials with a reported enrollment target (188% higher). The listed sponsor is Shu Mei Kato, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT02478931 reports 3 study locations spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT02478931 about?
NCT02478931 is a clinical study titled "Study of Personalized Cancer Therapy to Determine Response and Toxicity". The purpose of this study is to learn more about personalized cancer therapy including response to treatment and side effects. Information about the tests and treatments a person received, or will receive, for their cancer will be collected from medical records to help the researchers determine whet...
What is the current status of trial NCT02478931?
This trial is currently recruiting. The enrollment target is 10,000 participants. The study started on 2013-09-05. Estimated completion is 2026-09-05.
What conditions does trial NCT02478931 study?
This clinical trial studies the following conditions: Cancer.
Who is sponsoring clinical trial NCT02478931?
This trial is sponsored by Shu Mei Kato, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02478931 being conducted?
This trial has 3 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Registry Study to Evaluate the Clinical Outcome of Cancer Patients and Benign Diseases Treated with Radiation
RECRUITING
-
Treatment of Immune Checkpoint Inhibitor-related Diarrhea and/ or Colitis With Ustekinumab in Cancer Patients
RECRUITING · Phase 2
-
IMPACT (IMproving Proactive Approaches for Cancer Survivors' Mental Health Treatment)
RECRUITING · NA
-
A Natural History Study of Metabolic Sizing in Health and Disease
RECRUITING
-
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
RECRUITING · Phase 1
-
Long-Term Follow-Up of Recipient of Gene Transfer Research
RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.